Bills of Congress
H.R.1051 - To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes. (119th Congress)
H.R.1051 aims to amend the Federal Food, Drug, and Cosmetic Act concerning the approval process for generic drugs. Specifically, it addresses situations where the first applicant for a generic drug fails to bring their product to market within a defined …
H.R.1051 aims to amend the Federal Food, Drug, and Cosmetic Act concerning the approval process for generic drugs. Specifically, it …